Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma

Turning cold tumors hot: from molecular mechanisms to clinical applications

(2022) Jiahui Zhang et al.   TRENDS IN IMMUNOLOGY

Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD ‐1 therapeutic antibody: A follow‐up case report

(2022) Masaya Igase et al.   Veterinary and Comparative Oncology

Impact of Histotripsy on Development of Intrahepatic Metastases in a Rodent Liver Tumor Model

(2022) Tejaswi Worlikar et al.   Cancers

Regulation of PD-L1 expression in the tumor microenvironment

(2021) Ming Yi et al.   Journal of Hematology & Oncology

Neutralization of PD-L2 is Essential for Overcoming Immune Checkpoint Blockade Resistance in Ovarian Cancer

(2021) Yu Rebecca Miao et al.   CLINICAL CANCER RESEARCH

A brand new era of cancer immunotherapy: breakthroughs and challenges

(2021) Ri-Lan Bai et al.   CHINESE MEDICAL JOURNAL

Histotripsy Ablation of Bone Tumors: Feasibility Study in Excised Canine Osteosarcoma Tumors

(2021) Lauren Arnold et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

PD-1, PD-L1, and PD-L2 Gene Expression and Tumor Infiltrating Lymphocytes in Canine Melanoma

(2021) Valentina B. Stevenson et al.   VETERINARY PATHOLOGY

Immunological Effects of Histotripsy for Cancer Therapy

(2021) Alissa Hendricks-Wenger et al.   Frontiers in Oncology

Increase in tumour PD-L1 expression in non-small cell lung cancer following bronchoscopic thermal vapour ablation

(2021) Kanishka Rangamuwa et al.   Translational Lung Cancer Research

The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances

(2021) James R. Janopaul-Naylor et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review

(2021) Matthieu Roulleaux Dugage et al.   Frontiers in Immunology

Cancer-Immunity Cycle and Therapeutic Interventions- Opportunities for Including Pet Dogs With Cancer

(2021) Samantha K. Von Rueden et al.   Frontiers in Oncology

Abscopal effect in the radio and immunotherapy

(2021) Alina M. Pevzner et al.   Radiation Oncology Journal

Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination

(2020) Eleonore De Guillebon et al.   INTERNATIONAL JOURNAL OF CANCER

B cells are associated with survival and immunotherapy response in sarcoma

(2020) Florent Petitprez et al.   NATURE

Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy

(2020) Shibin Qu et al.   Journal for ImmunoTherapy of Cancer

Prognostic and clinical impact of PD-L2 and PD-L1 expression in a cohort of 437 oesophageal cancers

(2020) Kazuo Okadome et al.   BRITISH JOURNAL OF CANCER

Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function

(2020) Jin Wook Choi et al.   PLoS One

Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?

(2020) Cinzia Solinas et al.   Translational Oncology

Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes

(2020) Yarne Klaver et al.   Journal for ImmunoTherapy of Cancer

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma

(2019) Yiyin Zhang et al.   Journal for ImmunoTherapy of Cancer

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy

(2019) Hari Menon et al.   Journal for ImmunoTherapy of Cancer

Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes

(2019) Dolors Pi Castro et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse

(2018) Bingxin Zheng et al.   Journal of Hematology & Oncology

PD ‐L1 expression enhancement by infiltrating macrophage‐derived tumor necrosis factor‐α leads to poor pancreatic cancer prognosis

(2018) Masayo Tsukamoto et al.   CANCER SCIENCE

Clinicopathological analysis of PD-L2 expression in colorectal cancer

(2018) Peng-da Guo et al.   OncoTargets and Therapy

Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells

(2017) Xun Wang et al.   IMMUNOLOGY LETTERS

Soft tissue sarcoma in the dog - Part 2: surgical margins, controversies and a comparative review

(2017) J. P. Bray   JOURNAL OF SMALL ANIMAL PRACTICE

A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma

(2017) Naoya Maekawa et al.   Scientific Reports

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma

(2016) Chan Kim et al.   BMC CANCER

Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy

(2016) Panpan Zhang et al.   CANCER SCIENCE

PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor

(2016) L. Shi et al.   CLINICAL CANCER RESEARCH

Soft tissue sarcoma in the dog - part 1: a current review

(2016) J. P. Bray   JOURNAL OF SMALL ANIMAL PRACTICE

PD-L1 expression in human cancers and its association with clinical outcomes

(2016) Jinming Yu et al.   OncoTargets and Therapy

Histotripsy of the Prostate in a Canine Model: Characterization of Post-Therapy Inflammation and Fibrosis

(2015) Sarah E. Darnell et al.   JOURNAL OF ENDOUROLOGY

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

(2015) S. P. Patel et al.   MOLECULAR CANCER THERAPEUTICS

Prognostic Factors for Cutaneous and Subcutaneous Soft Tissue Sarcomas in Dogs

(2010) M. M. Dennis et al.   VETERINARY PATHOLOGY